The amount of the deal was not disclosed.
The company intends to use the funds for international expansion.
Led by Sebastian J. Schultheiss, Managing Director, Computomics offers bioinformatics analysis services to use high-throughput sequencing data. Services include genome assembly and annotation, genomic variation, transcriptomics, epigenetics, metagenomics, genomic selection, and phenotyping.
The company’s services also feature independence from sequencing platforms and vendors, transparent processes and scientific reproducibility of all analyses.
Computomics was co-founded in 2012 as a spin-off of the University of Tübingen and the Max Planck Institute for Developmental Biology by Schultheiss and Dr. Tobias Dezulian, who are scientists specialized on bioinformatics analyses of high-throughput DNA sequencing data, Dr. Detlef Weigel, Director of the Molecular Biology Department of the Max Planck Institute for Developmental Biology, Dr. Daniel Huson, Professor for Algorithms in Bioinformatics at the University of Tübingen, Dr. Gunnar Rätsch, Professor for Biomedical Informatics at the ETH Zurich, Dr. Karsten Borgwardt, Professor for Data Mining in the Biosystems Department of the ETH in Basel.